Free Trial

Arbutus Biopharma (ABUS) Earnings Date, Estimates & Call Transcripts

Arbutus Biopharma logo
$3.40 0.00 (0.00%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$3.36 -0.03 (-1.03%)
As of 08/8/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Arbutus Biopharma Earnings Summary

Arbutus Biopharma posted Q2 2025 earnings on August 6, 2025, reporting an EPS of $0.01, which topped analysts' consensus estimates of -$0.02 by $0.03. Quarterly revenue was reported to be $10.74 million, above analyst estimates of $2.21 million. With a trailing EPS of -$0.41, Arbutus Biopharma's earnings are expected to grow next year, from ($0.39) to ($0.34) per share.

Latest Q2
Earnings Date
Aug. 6Estimated
Consensus EPS
(Aug. 6)
-$0.02
Actual EPS
(Aug. 6)
$0.01 Beat By $0.03
Actual Revenue
(Aug. 6)
$10.74M

Q2 2025 Earnings Resources

Get Arbutus Biopharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arbutus Biopharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ABUS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ABUS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Arbutus Biopharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20251-$0.10-$0.10-$0.10
Q4 20251-$0.11-$0.11-$0.11

Arbutus Biopharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025-$0.02$0.01+$0.03$0.01$2.21M$10.74M
5/14/2025Q1 2025-$0.09-$0.13 -$0.04-$0.13$2.54M$1.76M
3/27/2025Q4 2024-$0.08-$0.07+$0.01-$0.07$2.20M$1.57M
8/1/2024Q2 2024-$0.10-$0.11 -$0.01-$0.11$1.54M$1.73M
5/2/2024Q1 2024-$0.10-$0.10--$0.10$2.16M$1.53M
2/29/2024Q4 2023-$0.12-$0.12--$0.12$4.74M$2.15M
11/7/2023Q3 2023-$0.12-$0.12--$0.12$3.78M$4.66M

Arbutus Biopharma Earnings - Frequently Asked Questions

Arbutus Biopharma (NASDAQ:ABUS) last announced its quarterly earning data on Wednesday, August 6, 2025. Learn more on ABUS's earnings history.

In the previous quarter, Arbutus Biopharma (NASDAQ:ABUS) reported $0.01 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.02) by $0.03. Learn more on analysts' earnings estimate vs. ABUS's actual earnings.

Arbutus Biopharma's earnings report can be found in their filing with the SEC.
View SEC filing

Arbutus Biopharma (NASDAQ:ABUS) has a recorded annual revenue of $6.17 million.

Arbutus Biopharma (NASDAQ:ABUS) has a recorded net income of -$69.92 million. ABUS has generated -$0.41 earnings per share over the last four quarters.

Arbutus Biopharma's earnings are expected to grow from ($0.39) per share to ($0.34) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ABUS) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners